Arkolith/Insider Trading/DRNA/Form 4

Doberstein Stephen K

DirectorDicerna Pharmaceuticals Inc (DRNA) · full profile →Form 4 · filed Dec 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Tender(U)3K$38.25$127K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 28, 2021Disposed to issuer(D)15K——0
Dec 28, 2021Disposed to issuer(D)15K——0
Dec 28, 2021Disposed to issuer(D)3K——0
Dec 28, 2021Disposed to issuer(D)25K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001399529-21-000197) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML